A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Adults.
Clinical trial NCT06467370 · COMPLETED
Trial details
- NCT number
- NCT06467370
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-02
- Primary completion
- 2025-03-11
- Enrollment
- 467
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.